Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of the European Academy of Dermatology and Venereology|
|State||Published - Mar 1 2003|
- Actinic keratosis
ASJC Scopus subject areas
- Infectious Diseases